Tokyo, Nov. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059886) titled 'Observational studies on malignant pleural effusions' on Nov. 26.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Malignant tumors including lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To elucidate the characteristics of cancer patients with body cavity effusion through analyses of laboratory findings of effusion samples, clinical courses, and various assessments using previously collected specimens.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with a pathologically confirmed diagnosis of malignant neoplasm.
Patients with active malignant disease who underwent collection of body cavity effusion (e.g., therapeutic drainage or diagnostic aspiration) due to suspected malignant pleuritis, peritonitis, or pericarditis.
Patients who have been seen in the Department of Respiratory Medicine or the Department of Thoracic Surgery.
Key exclusion criteria - Patients deemed inappropriate for participation in this study by the principal investigator or a co-investigator.
Patients who have requested not to participate in this study.
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2023 Year 10 Month 31 Day
Date of IRB - 2023 Year 10 Month 31 Day
Anticipated trial start date - 2023 Year 10 Month 31 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059776
Disclaimer: Curated by HT Syndication.
